Biotech, Cannabis, Food & Drug, & Pharma Law Updates

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Title
Publication Date Organization
Jul
29
2015
Emerging State Biosimilar Laws – Reference Chart and Five Issues to Watch Mintz
Jul
28
2015
Bio/Pharma IPR Challenges Nearly Double In 2015 Foley & Lardner LLP
Jul
28
2015
Does CPSC or FDA Have Jurisdiction Over Your Consumer Product? Mintz
Jul
28
2015
GlaxoSmithKline Seeks Consolidation of Zofran Lawsuits in Federal Court Stark & Stark
Jul
28
2015
America Invents Act: Can You File An RCE In That U.S. National Stage Application? Foley & Lardner LLP
Jul
28
2015
Amneal Pharm v. Endo Pharmaceuticals: Final Written Decision Finding Claim Limitation Not Inherently Disclosed IPR2014-00360 Faegre Drinker
Jul
27
2015
FDA Proposes Further Revisions to Nutritional Facts Label Michael Best & Friedrich LLP
Jul
27
2015
FDA Issues Proposed Rule and Draft Guidance on User Fee Program for Accreditation of Third-Party Auditors-Certification Bodies to Conduct Food Safety Audits and To Issue Certifications Barnes & Thornburg LLP
Jul
27
2015
FDA Issues Proposed Rule on Disclosing Added Sugars on Nutrition Facts Label Barnes & Thornburg LLP
Jul
27
2015
Kaneka v. Xiamen Kingdomway Group: Implicit Order Read into Method Steps of Industrial Biotechnology Patent Sterne, Kessler, Goldstein & Fox P.L.L.C.
Jul
27
2015
School Bus Driver’s Alcohol-Laced Cupcakes Did Not Violate Employer’s Rule Barring Intoxicating Beverages From Company Property, Arbitrator Rules Jackson Lewis P.C.
Jul
27
2015
Medical Marijuana Business Expenses Are Not Tax Deductible, Court Holds Jackson Lewis P.C.
Jul
25
2015
North Carolina Reinforces Property Protection Law, Giving Employers Right to Sue Jackson Lewis P.C.
Jul
25
2015
New Hawaii Medical Marijuana Law Bars Use in Workplace; Zero Tolerance Policies Still Enforceable Jackson Lewis P.C.
Jul
24
2015
FDA Proposes Rule and Releases Guidance on Third-Party Auditor Program to Expedite Qualified Foreign Food Imports Morgan, Lewis & Bockius LLP
Jul
24
2015
FDA Leverages Patient-Reported Information to Monitor Drug Safety Epstein Becker & Green, P.C.
Jul
24
2015
The Safe and Accurate Food Labeling Act Restricts State and Local Government from Regulating GMO in Food ArentFox Schiff LLP
Jul
24
2015
Federal Circuit Clarifies the Steps in Biosimilars Dance Hunton Andrews Kurth
Jul
24
2015
U.S. House Passes GMO Labeling Legislation Mintz
Jul
24
2015
Modernizing and Coordinating the Regulatory System of Biotechnology Products Wilson Elser Moskowitz Edelman & Dicker LLP
Jul
23
2015
Biosimilars, the BPCIA, and Amgen v. Sandoz: The Federal Circuit’s First Attempt To Make Sense of “A Riddle Wrapped in a Mystery Inside an Enigma” Mintz
Jul
23
2015
The Riddle Wrapped in a Mystery Inside an Enigma – the Federal Circuit decides Amgen v. Sandoz – is anyone happy? Michael Best & Friedrich LLP
Jul
22
2015
FDA Issues Warning Letter to Corporate Sponsor of Clinical Trial Mintz
Jul
21
2015
Cheers! A Brief Look at Recent Changes to the Illinois Liquor Control Act Heyl, Royster, Voelker & Allen, P.C.
Jul
21
2015
DNA Sequencing Patents: Simultaneous Invention As Secondary Evidence Of Obviousness Foley & Lardner LLP
Jul
20
2015
The Patchwork Solidifies: GMO Bill Moves Forward in the House Mintz
Jul
17
2015
SEC Settles With Stock Promoters in Medical Marijuana Stock Manipulation Scheme Katten
Jul
17
2015
Federal GMO-Labeling Bill is on the Move as the House Agriculture Committee Approves H.R. 1599, the Safe and Accurate Food Labeling Act Michael Best & Friedrich LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins